No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Lesch Nyhan Syndrome (LNS) is a rare genetic disorder that affects the metabolism of purines, leading to an accumulation of uric acid in the body. Endocrine and Metabolic Disorders Drugs are used to treat the symptoms of LNS, including neurological and behavioral problems. These drugs are used to reduce the production of uric acid, as well as to reduce the risk of kidney stones and other complications. Commonly prescribed drugs include allopurinol, febuxostat, and rasburicase.
The Lesch Nyhan Syndrome Drug market is a niche market, with a limited number of companies offering treatments. Companies in the market include Sanofi, Pfizer, and Merck, as well as smaller companies such as BioMarin Pharmaceuticals and Alexion Pharmaceuticals. These companies are focused on developing treatments for LNS, as well as providing support and education to patients and their families. Show Less Read more
